查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654421

ELISpot 和 Fluorospot 检测市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025-2030 年

ELISpot And Fluorospot Assay Market Size, Share & Trends Analysis Report By Product (Prospective, Retrospective), By Application (Oncology, Neurology, Cardiology), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

ELISpot 和 Fluorospot 检测的市场趋势

2024 年全球 ELISpot 和 Fluorospot 检测市场规模估计为 3.118 亿美元，预计 2025 年至 2030 年期间的复合年增长率为 6.3%。这种增长归因于慢性病和感染疾病的增加、药物研发活动的增加、研究和诊断应用的增加以及临床前和临床环境中受监管的生物分析的扩展。 ELISpot 和 Fluorospot 检测用于评估免疫反应，在了解各种疾病（包括癌症）对免疫系统的影响方面发挥越来越重要的作用。

ELISpot 和 Fluorospot 检测用于检测和表征可作为癌症免疫治疗合适介质的自然产生的肿瘤反应性 T 细胞。此外，这些检测也用于表位图谱、肿瘤抗原鑑定以及监测疫苗诱导的 T 细胞和 B 细胞反应。此外，肝细胞癌（HCC）和子宫颈癌的发展分别与人类乳突病毒（HPV）和B型肝炎病毒（HBV）的高风险感染密切相关。肿瘤特异性疫苗经常在动物模型和细胞株中进行测试。例如，已经使用 IFN-Y 和 IL-2 ELISPOT 检测法在小鼠和细胞株中对人类乳突病毒(HPV)疫苗进行了评估。

透过 IFN-Y ELISPOT 检测发现转移性子宫颈癌患者中抗原特异性T 细胞反应的产生有助于研究人员开发新的治疗策略。研究人员正致力于透过装载肿瘤 DNA 或肿瘤匀浆的树突状细胞诱导肿瘤特异性细胞毒性 T 淋巴细胞 (CTL) 来阻止癌症进展。另一种方法是使用编码肿瘤抗原的病毒载体（例如腺病毒载体）产生基因疫苗。肿瘤特异性CTL反应可以透过ELISPOT分析来确定。

IFN-Y ELISPOT 检测也用于评估高剂量 IL-2 治疗对转移性黑色素瘤和肾细胞癌患者的免疫学效果。随着癌症发生率的增加，ELISpot 和 Fluorospot 检测在癌症研究中的应用越来越广泛，预计这也将推动需求的成长。根据美国国家癌症美国的资料，预计每年癌症病例数将增加至2,990万，癌症相关死亡人数将达1,530万人。预计癌症患者数量的快速增加将在预测期内推动市场成长。

这些检测为评估潜在药物对免疫系统的影响提供了强而有力的工具。 ELISpot 已成为多种疾病疫苗开发的重要工具，包括免疫力缺乏、疟疾、结核病、癌症和流感。 ELISpot 测试广泛用于临床试验以评估疫苗。根据世界卫生组织 (WHO) 国际临床实验室註册平台 (ICTRP) 的资料，仅在 2022 年全球就进行了 54,952 次临床测试。临床测试和药物发现活动的增加预计将增加对 ELISpot 和 Fluorospot 检测的需求，从而推动市场成长。

此外，一些市场参与企业正在加强透过 ELISpot 和 Fluorospot 检测为各种健康状况开发先进的解决方案，这进一步推动了市场成长。例如，2023 年 11 月，Revvity 宣布在印度推出采用 FDA核准的ELISPOT 技术的 T-SPOT 测试，用于潜伏性结核病筛检。此测试使用标准化样本，不易受到影响测试表现的血液因素的影响，并能使 T 细胞计数正常化。

目录

第一章调查方法与范围

第 2 章执行摘要

3. ELISpot 和 Fluorospot 检测市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章 ELISpot 和 Fluorospot 检测市场：产品业务分析

  • 2024 年及 2030 年产品市场占有率
  • 产品细分仪表板
  • 2018 年至 2030 年按产品分類的市场规模、预测与趋势分析
  • 检测试剂套件
  • 分析设备
  • 互补产品

5. ELISpot 和 Fluorospot 检测市场：应用业务分析

  • 2024 年和 2030 年应用市场占有率
  • 应用程式细分仪表板
  • 2018 年至 2030 年按应用分類的市场规模、预测与趋势分析
  • 研究用途
  • 诊断用途

6. ELISpot 和 Fluorospot 检测市场-最终用途业务分析

  • 2024 年及 2030 年终端用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 医院和临床实验室
  • 学术研究所
  • 生物製药公司

7. ELISpot 和 Fluorospot 检测市场（按地区划分）、估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 按国家/地区，2018-2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 依国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 依国家/地区，2018 年至 2030 年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018-2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • BD
    • U-CyTech
    • Cellular Technology Limited
    • Mabtech
    • Abcam Limited
    • Autoimmun Diagnostika GmbH
    • Lophius Biosciences GmbH
    • Bio-Connect BV
    • Oxford Immunotec
    • Bio-Techne Corporation
Product Code: GVR-4-68040-349-9

ELISpot And Fluorospot Assay Market Trends:

The global ELISpot and fluorospot assay market size was estimated at USD 311.8 million in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2030. This growth can be attributed to the rising incidences of chronic and infectious diseases, increasing drug discovery activities, rising adoption in research and diagnostics, and expanding pre-clinical and clinically regulated bioanalysis. The ELISpot and fluorospot assays are used to access immune responses, increasing their importance in understanding the effect of various diseases on the immune system, including cancer.

ELISpot and Fluorospot assay are used to detect and characterize naturally occurring tumor-reactive T-cells, which serve as suitable mediators of cancer immunotherapy. Moreover, these assays are also being used for epitope mapping, identification of tumor antigens, and monitor vaccine-induced T and B-cell responses. Moreover, the development of hepatocellular carcinoma (HCC) and cervical cancer is closely linked to high-risk infections with human papillomavirus (HPV) and hepatitis B virus (HBV), respectively. Tumor-specific vaccines are frequently tested in animal models and cell lines; for example, the HPV vaccine was assessed in mice and cell lines using the IFN-Y and IL-2 ELISPOT assay.

Detection of antigen-specific T cell responses via the IFN-Y ELISPOT assay in a patient with metastatic cervical cancer aids researchers in developing new treatment strategies. Researchers are working to halt cancer progression by inducing tumor-specific cytotoxic T lymphocytes (CTLs) through dendritic cells loaded with tumor DNA or tumor homogenate. Another approach involves generating virus-vectored genetic vaccines, such as using an Adenovirus vector encoding tumor antigens. The response of tumor-specific CTLs can be determined by the ELISPOT assay.

The IFN-Y ELISPOT assay is also used to evaluate the immunological efficacy of high-dose IL-2 treatment in patients with metastatic melanoma and renal cell carcinoma. These increasing applications of ELISpot and Fluorospot assays in cancer research are anticipated to drive their demand with increasing cancer incidences. According to National Cancer Institute data, the number of cancer cases per year is anticipated to increase to 29.9 million and cancer-related deaths to reach 15.3 million. This surge in cancer cases is anticipated to drive the market growth over the forecast period.

These assays provide a powerful tool for assessing a potential drug substance's effect on the immune system. ELISpot is emerging as a critical tool in vaccine development for various conditions, such as immunodeficiency syndrome (AIDS), malaria, tuberculosis, cancer, and flu. The ELISpot test is widely utilized in clinical studies to evaluate vaccines. According to the World Health Organization's (WHO) International Clinical Trials Registry Platform (ICTRP) data, 54,952 clinical trials were performed globally in 2022 alone. These increasing clinical trials and drug discovery activities are expected to increase the demand for ELISpot and Fluorospot assay, thereby driving market growth.

Moreover, several market players are increasing their efforts to develop advanced solutions based on ELISpot and Fluorospot assays for various health conditions, which is further driving the market growth. For instance, in November 2023, Revvity announced the launch of its FDA-approved ELISPOT technology-based T-SPOT test in India for latent TB screening. The test uses a standardized sample, which reduces the influence of blood factors that can impact the test performance and normalization for T-cell count.

Global ELISpot And Fluorospot Assay Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ELISpot and fluorospot assay market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Assay Kits
  • Analyzers
  • Ancillary Products
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital and Clinical Labs
  • Academic and Research Institutes
  • Biopharmaceutical Company
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. ELISpot and Fluorospot Assay Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. ELISpot and Fluorospot Assay Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Assay Kits
    • 4.4.1. Assay Kits Market, 2018 - 2030 (USD Million)
  • 4.5. Analyzers
    • 4.5.1. Analyzers Market, 2018 - 2030 (USD Million)
  • 4.6. Ancillary Products
    • 4.6.1. Ancillary Products Market, 2018 - 2030 (USD Million)

Chapter 5. ELISpot and Fluorospot Assay Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Applications
    • 5.4.1. Research Applications Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostics Applications
    • 5.5.1. Diagnostics Applications Market, 2018 - 2030 (USD Million)

Chapter 6. ELISpot and Fluorospot Assay Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital and Clinical Labs
    • 6.4.1. Hospital and Clinical Labs Market, 2018 - 2030 (USD Million)
  • 6.5. Academic and Research Institutes
    • 6.5.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Biopharmaceutical Company
    • 6.6.1. Biopharmaceutical Company Market, 2018 - 2030 (USD Million)

Chapter 7. ELISpot and Fluorospot Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. BD
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. U-CyTech
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Cellular Technology Limited
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Mabtech
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Abcam Limited
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Autoimmun Diagnostika GmbH
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Lophius Biosciences GmbH
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Bio-Connect B.V.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Oxford Immunotec
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Bio-Techne Corporation
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global ELISpot and fluorospot assay market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 31 France ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 32 France ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 44 Denmark ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 47 Sweden ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 56 China ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 57 China ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 59 India ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 60 India ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 65 South Korea ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 66 South Korea ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 69 Thailand ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ELISpot and fluorospot assay market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 ELISpot and fluorospot assay market dynamics
  • Fig. 13 ELISpot and fluorospot assay market: Porter's five forces analysis
  • Fig. 14 ELISpot and fluorospot assay market: PESTLE analysis
  • Fig. 15 ELISpot and fluorospot assay market: Product segment dashboard
  • Fig. 16 ELISpot and fluorospot assay market: Product market share analysis, 2024 & 2030
  • Fig. 17 Assay kits market, 2018 - 2030 (USD Million)
  • Fig. 18 Analyzers market, 2018 - 2030 (USD Million)
  • Fig. 19 Ancillary products market, 2018 - 2030 (USD Million)
  • Fig. 20 ELISpot and fluorospot assay market: Application segment dashboard
  • Fig. 21 ELISpot and fluorospot assay market: Application market share analysis, 2024 & 2030
  • Fig. 22 Research applications market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostics applications market, 2018 - 2030 (USD Million)
  • Fig. 24 ELISpot and fluorospot assay market: End use segment dashboard
  • Fig. 25 ELISpot and fluorospot assay market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospital and clinical labs market, 2018 - 2030 (USD Million)
  • Fig. 27 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical company market, 2018 - 2030 (USD Million)
  • Fig. 29 ELISpot and fluorospot assay market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 44 France country dynamics
  • Fig. 45 France ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 59 China country dynamics
  • Fig. 60 China ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 61 India country dynamics
  • Fig. 62 India ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 74 MEA ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework